Devanarayan V - Search Results

1

Decrease in age-adjusted cerebrospinal fluid beta-secretase activity in Alzheimer's subjects.

Wu G, Sankaranarayanan S, Tugusheva K, Kahana J, Seabrook G, Shi XP, King E, Devanarayan V, Cook JJ, Simon AJ. Wu G, et al. Among authors: devanarayan v. Clin Biochem. 2008 Aug;41(12):986-96. doi: 10.1016/j.clinbiochem.2008.04.022. Epub 2008 May 6. Clin Biochem. 2008. PMID: 18489907

2

First demonstration of cerebrospinal fluid and plasma A beta lowering with oral administration of a beta-site amyloid precursor protein-cleaving enzyme 1 inhibitor in nonhuman primates.

Sankaranarayanan S, Holahan MA, Colussi D, Crouthamel MC, Devanarayan V, Ellis J, Espeseth A, Gates AT, Graham SL, Gregro AR, Hazuda D, Hochman JH, Holloway K, Jin L, Kahana J, Lai MT, Lineberger J, McGaughey G, Moore KP, Nantermet P, Pietrak B, Price EA, Rajapakse H, Stauffer S, Steinbeiser MA, Seabrook G, Selnick HG, Shi XP, Stanton MG, Swestock J, Tugusheva K, Tyler KX, Vacca JP, Wong J, Wu G, Xu M, Cook JJ, Simon AJ. Sankaranarayanan S, et al. Among authors: devanarayan v. J Pharmacol Exp Ther. 2009 Jan;328(1):131-40. doi: 10.1124/jpet.108.143628. Epub 2008 Oct 14. J Pharmacol Exp Ther. 2009. PMID: 18854490

3

Evaluation of plasma proteomic data for Alzheimer disease state classification and for the prediction of progression from mild cognitive impairment to Alzheimer disease.

Llano DA, Devanarayan V, Simon AJ; Alzheimer’s Disease Neuroimaging Initiative (ADNI). Llano DA, et al. Among authors: devanarayan v. Alzheimer Dis Assoc Disord. 2013 Jul-Sep;27(3):233-43. doi: 10.1097/WAD.0b013e31826d597a. Alzheimer Dis Assoc Disord. 2013. PMID: 23023094

4

Screening for new biomarkers for subcortical vascular dementia and Alzheimer's disease.

Ohrfelt A, Andreasson U, Simon A, Zetterberg H, Edman A, Potter W, Holder D, Devanarayan V, Seeburger J, Smith AD, Blennow K, Wallin A. Ohrfelt A, et al. Among authors: devanarayan v. Dement Geriatr Cogn Dis Extra. 2011 Jan;1(1):31-42. doi: 10.1159/000323417. Epub 2011 Jan 14. Dement Geriatr Cogn Dis Extra. 2011. PMID: 22163231 Free PMC article.

5

Using CSF biomarkers to replicate genetic associations in Alzheimer's disease.

Schott JM; ADNI Investigators. Schott JM, et al. Neurobiol Aging. 2012 Jul;33(7):1486.e9-15. doi: 10.1016/j.neurobiolaging.2011.02.008. Epub 2011 Apr 3. Neurobiol Aging. 2012. PMID: 21459483 Free PMC article.

6

Cerebrospinal fluid cytokine dynamics differ between Alzheimer disease patients and elderly controls.

Llano DA, Li J, Waring JF, Ellis T, Devanarayan V, Witte DG, Lenz RA. Llano DA, et al. Among authors: devanarayan v. Alzheimer Dis Assoc Disord. 2012 Oct-Dec;26(4):322-8. doi: 10.1097/WAD.0b013e31823b2728. Alzheimer Dis Assoc Disord. 2012. PMID: 22089638

7

Localized hippocampus measures are associated with Alzheimer pathology and cognition independent of total hippocampal volume.

Carmichael O, Xie J, Fletcher E, Singh B, DeCarli C; Alzheimer's Disease Neuroimaging Initiative. Carmichael O, et al. Neurobiol Aging. 2012 Jun;33(6):1124.e31-41. doi: 10.1016/j.neurobiolaging.2011.08.016. Epub 2011 Dec 14. Neurobiol Aging. 2012. PMID: 22169204 Free PMC article.

8

VGF in Cerebrospinal Fluid Combined With Conventional Biomarkers Enhances Prediction of Conversion From MCI to AD.

Llano DA, Devanarayan P, Devanarayan V; Alzheimer’s Disease Neuroimaging Initiative (ADNI). Llano DA, et al. Among authors: devanarayan p, devanarayan v. Alzheimer Dis Assoc Disord. 2019 Oct-Dec;33(4):307-314. doi: 10.1097/WAD.0000000000000328. Alzheimer Dis Assoc Disord. 2019. PMID: 31305322

9

Comparison of Titer and Signal to Noise (S/N) for Determination of Anti-drug Antibody Magnitude Using Clinical Data from an Industry Consortium.

Starcevic Manning M, Hassanein M, Partridge MA, Jawa V, Mora J, Ryman J, Barker B, Braithwaite C, Carleton K, Hay L, Hottenstein C, Kubiak RJ, Devanarayan V. Starcevic Manning M, et al. Among authors: devanarayan v. AAPS J. 2022 Jul 12;24(4):81. doi: 10.1208/s12248-022-00728-8. AAPS J. 2022. PMID: 35821280

10

Identification of a Simple and Novel Cut-Point Based Cerebrospinal Fluid and MRI Signature for Predicting Alzheimer's Disease Progression that Reinforces the 2018 NIA-AA Research Framework.

Devanarayan P, Devanarayan V, Llano DA; Alzheimer’s Disease Neuroimaging Initiative. Devanarayan P, et al. Among authors: devanarayan v. J Alzheimers Dis. 2019;68(2):537-550. doi: 10.3233/JAD-180905. J Alzheimers Dis. 2019. PMID: 30775985

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

79 results

Search Page

Filters